Homologous Recombinant Deficiency Does Not Share Morphologic Surrogates of BRCAmutated High-Grade Serous Carcinoma

被引：0
|
作者：
Jia, Xiaohan [1 ]
DeCoteau, John [1 ]
Koebel, Martin
Lee, Cheng-Han [2 ]
Hopkins, Laura [1 ]
Clairefond, Sylvie [1 ]
Le, Thuy [1 ]
Kinloch, Marilyn [1 ]
机构：
[1] Univ Saskatchewan, Saskatoon, SK, Canada
[2] Univ Alberta, Edmonton, AB, Canada
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
932
引用
收藏
页码：S1168 / S1169
页数：2
相关论文
共 50 条
  • [41] Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma
    Brett M. Reid
    Shraddha Vyas
    Zhihua Chen
    Ann Chen
    Peter A. Kanetsky
    Jennifer B. Permuth
    Thomas A. Sellers
    Ozlen Saglam
    BMC Cancer, 21
  • [42] Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma
    Reid, Brett M.
    Vyas, Shraddha
    Chen, Zhihua
    Chen, Ann
    Kanetsky, Peter A.
    Permuth, Jennifer B.
    Sellers, Thomas A.
    Saglam, Ozlen
    BMC CANCER, 2021, 21 (01)
  • [43] Clinical Outcomes of Patients with High-Grade Ovarian Carcinoma Arising in Endometriosis Compared to Ovarian High-Grade Serous Carcinoma
    Ibrahim Yalcin
    Hanifi Sahin
    Mustafa Erkan Sari
    Asuman Nihan Haberal
    Eda Adeviye Sahin
    Husnu Celik
    Mehmet Mutlu Meydanli
    Ali Ayhan
    Indian Journal of Gynecologic Oncology, 2021, 19
  • [44] Clinical Outcomes of Patients with High-Grade Ovarian Carcinoma Arising in Endometriosis Compared to Ovarian High-Grade Serous Carcinoma
    Yalcin, Ibrahim
    Sahin, Hanifi
    Sari, Mustafa Erkan
    Haberal, Asuman Nihan
    Sahin, Eda Adeviye
    Celik, Husnu
    Meydanli, Mehmet Mutlu
    Ayhan, Ali
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
  • [45] Increased p16 Expression in High-grade Serous and Undifferentiated Carcinoma Compared With Other Morphologic Types of Ovarian Carcinoma
    Phillips, V.
    Kelly, P.
    McCluggage, W. Glenn
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2009, 28 (02) : 179 - 186
  • [46] Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer
    Bouberhan, Sara
    Philp, Lauren
    Hill, Sarah
    Al-Alem, Linah F.
    Rueda, Bo
    CANCERS, 2020, 12 (05)
  • [47] A subgroup with a T-cell inflamed phenotype in homologous recombination proficient high-grade serous ovarian carcinoma
    Hasegawa, Kosei
    Matsushita, Hirokazu
    Oda, Katsutoshi
    Yamamoto, Shogo
    Asada, Kayo
    Nishijima, Akira
    Karasaki, Takahiro
    Ikeda, Yuji
    Fujiwara, Keiichi
    Aburatani, Hiroyuki
    Kakimi, Kazuhiro
    CANCER SCIENCE, 2018, 109 : 667 - 667
  • [48] Intratumoral heterogeneity and drug response in high-grade serous carcinoma
    Brenton, James D.
    CLINICAL CANCER RESEARCH, 2013, 19
  • [49] Single cell multiomic profiling of high-grade serous carcinoma
    Sandoval, Leticia Assad Maia
    Ismail, Wazim Mohammed
    Mazzone, Amelia
    Munankarmy, Amik
    Kaur, Jagneet
    Tashi, Tsering
    Hou, Xiaonan
    Kannan, Nagarajan
    Oberg, Ann
    Kaufmann, Scott H.
    Weroha, Saravut John
    Gaspar-Maia, Alexandre
    CANCER RESEARCH, 2023, 83 (07)
  • [50] HMGA2 and high-grade serous ovarian carcinoma
    Jingjing Wu
    Jian-Jun Wei
    Journal of Molecular Medicine, 2013, 91 : 1155 - 1165
12345